Alpelisib 150mg is an oral targeted therapy designed to treat patients with HR-positive, HER2-negative advanced or metastatic breast cancer who have a specific genetic mutation — PIK3CA mutation. This innovative medication is often prescribed in combination with fulvestrant for postmenopausal women and men whose cancer has progressed after hormone therapy.

How Does Alpelisib Work?

Alpelisib works by inhibiting the PI3K pathway, which is frequently overactivated in certain types of breast cancer. By blocking this pathway, Alpelisib helps slow down or stop cancer cell growth, giving patients a better chance at disease control.

How to Take this Tablet

Take it with food at the same time every day to maximize its effectiveness. Your doctor will determine the correct dosage based on your medical condition and response to treatment.

Following your doctor’s instructions is crucial, as incorrect usage or overdosing can lead to severe side effects. It may take several weeks or months to see noticeable improvements, so continue taking the medication unless your doctor advises otherwise.

Side Effects of Alpelisib 150mg

Like all cancer medications, Alpelisib can cause side effects. Common side effects include:

• High blood sugar (hyperglycemia)
• Rash and skin reactions
• Diarrhea
• Nausea
• Fatigue
• Loss of appetite
• Mouth sores

Your doctor will closely monitor your blood sugar levels and general health throughout treatment.

Disclaimer

RxLane provides information for educational purposes only. All trademarks, brands, and service marks are the property of their respective owners. RxLane does not offer medical advice. Please consult your doctor for appropriate diagnosis and treatment. This content is intended for wholesalers, doctors, hospitals, clinics, pharmacies, and medical institutions.